These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30707500)

  • 1. Design, Synthesis, and Evaluation of Lipopeptide Conjugates of Mercaptoundecahydrododecaborate for Boron Neutron Capture Therapy.
    Isono A; Tsuji M; Sanada Y; Matsushita A; Masunaga S; Hirayama T; Nagasawa H
    ChemMedChem; 2019 Apr; 14(8):823-832. PubMed ID: 30707500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
    Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H
    Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells.
    Genady AR; Ioppolo JA; Azaam MM; El-Zaria ME
    Eur J Med Chem; 2015 Mar; 93():574-83. PubMed ID: 25748122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembling A6K peptide nanotubes as a mercaptoundecahydrododecaborate (BSH) delivery system for boron neutron capture therapy (BNCT).
    Michiue H; Kitamatsu M; Fukunaga A; Tsuboi N; Fujimura A; Matsushita H; Igawa K; Kasai T; Kondo N; Matsui H; Furuya S
    J Control Release; 2021 Feb; 330():788-796. PubMed ID: 33188824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
    Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Gotoh K; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Radiat Med; 2006 Feb; 24(2):98-107. PubMed ID: 16715670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boron-enriched streptavidin potentially useful as a component of boron carriers for neutron capture therapy of cancer.
    Sano T
    Bioconjug Chem; 1999; 10(5):905-11. PubMed ID: 10502360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Block copolymer-boron cluster conjugate for effective boron neutron capture therapy of solid tumors.
    Mi P; Yanagie H; Dewi N; Yen HC; Liu X; Suzuki M; Sakurai Y; Ono K; Takahashi H; Cabral H; Kataoka K; Nishiyama N
    J Control Release; 2017 May; 254():1-9. PubMed ID: 28336377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectromicroscopy of boron in human glioblastomas following administration of Na2B12H11SH.
    Gilbert B; Perfetti L; Fauchoux O; Redondo J; Baudat PA; Andres R; Neumann M; Steen S; Gabel D; Mercanti D; Ciotti MT; Perfetti P; Margaritondo G; De Stasio G
    Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics; 2000 Jul; 62(1 Pt B):1110-8. PubMed ID: 11088567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategy for synthesis of mercaptoundecahydrododecaborate derivatives via click chemistry: possible boron carriers and visualization in cells for neutron capture therapy.
    El-Zaria ME; Nakamura H
    Inorg Chem; 2009 Dec; 48(24):11896-902. PubMed ID: 19928788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Studies to Define the Cell-Surface and Intracellular Targets of Polyarginine-Conjugated Sodium Borocaptate as a Potential Delivery Agent for Boron Neutron Capture Therapy.
    Fujimura A; Yasui S; Igawa K; Ueda A; Watanabe K; Hanafusa T; Ichikawa Y; Yoshihashi S; Tsuchida K; Kamiya A; Furuya S
    Cells; 2020 Sep; 9(10):. PubMed ID: 32977522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of mercaptoundecahydrododecaborate (BSH) with phosphatidylcholine: relevance to boron neutron capture therapy.
    Kageji T; Otersen B; Gabel D; Huiskamp R; Nakagawa Y; Matsumoto K
    Biochim Biophys Acta; 1998 Apr; 1391(3):377-83. PubMed ID: 9555099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy of cancers.
    Koganei H; Ueno M; Tachikawa S; Tasaki L; Ban HS; Suzuki M; Shiraishi K; Kawano K; Yokoyama M; Maitani Y; Ono K; Nakamura H
    Bioconjug Chem; 2013 Jan; 24(1):124-32. PubMed ID: 23214414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT).
    Haritz D; Gabel D; Huiskamp R
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1175-81. PubMed ID: 8175403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma.
    Kageji T; Nagahiro S; Kitamura K; Nakagawa Y; Hatanaka H; Haritz D; Grochulla F; Haselsberger K; Gabel D
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):120-30. PubMed ID: 11516861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of the high-LET radiations from the boron neutron capture [10B(n,α) 7Li] reaction determined for induction of chromosome aberrations and apoptosis in lymphocytes of human blood samples.
    Schmid TE; Canella L; Kudejova P; Wagner FM; Röhrmoser A; Schmid E
    Radiat Environ Biophys; 2015 Mar; 54(1):91-102. PubMed ID: 25428113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.